Dr. Efrain D. Salgado, MD

Dr. Salgado practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Salgado's NPI, 1699739029, was assigned on April 13, 2006. Dr. Salgado graduated from Universidad Central del Caribe School of Medicine in 1981. Dr. Salgado holds Florida license ME0058326.

Dr. Salgado's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Salgado's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Salgado is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salgado practices. Vendor and product names are available with a free account.

Neurology is Dr. Salgado's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Salgado is board certified in electrodiagnostic medicine by the ABEM. Dmand AI has Dr. Salgado's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain, headaches and lower back pain among the conditions Dr. Salgado treats.

CMS data shows 422 Medicare services from Dr. Salgado across 9 procedure codes in 2024, for 285 Medicare patients. Medicare paid $28,770 for them.

CMS counts 285 Medicare patients who saw Dr. Salgado in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salgado's median patient age at 66, with 56% women.

In 2024, Dr. Salgado wrote 1,045 Medicare Part D claims for 172 patients. 83% of them were for generic drugs. CMS names the drug for 822 of them, across 32 drugs with 11 or more claims each, at $827,266 in total drug cost. In 2023, CMS named 1,015 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Salgado for performance year 2024, reported through an alternative payment model (APM). Dr. Salgado accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Salgado, published from 2011 to 2016. 2012 was the busiest year, with 4. The most frequent topics are Stroke, Antibodies, Monoclonal, Humanized and Cerebral Infarction. Dr. Salgado has published most often in Ann Neurol. Dr. Salgado's most frequent co-authors are Raghav Govindarajan, MD, John Anthony Morren, MD and Jonathan Douglas Santoro.

CMS Open Payments shows 210 general payments to Dr. Salgado from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $378.

Dmand AI lists 3 awards for Dr. Salgado, most recently CMS Stage 1 EHR in 2013.

Dr. Salgado graduated from Universidad Central del Caribe School of Medicine in 1981.

Dr. Salgado is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.